研究成果
年分
作者
期刊
研究名稱
2022
Bruckert E*, Caprio S, Wiegman A, Charng MJ, Zarate-Morales CA, Baccara-Dinet MT, Manvelian G, Ourliac A, Scemama M, Daniels SR.
Arterioscler. Thromb. Vasc. Biol. 2022; 42(12): 1447-1457. (IF:10.514)
Efficacy and Safety of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia: Phase 3, Multinational Open-Label Study.
2022
Butt JH, Dewan P, Merkely B, Belohlavek J, Drozdz J, Kitakaze M,......McMurray JJV*.
Ann. Intern. Med. 2022; 175(6): 820 -830. (IF: 51.598)
Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction A Post Hoc Analysis of the DAPA-HF Trial.
2022
Carnicelli AP, Hong H, Connolly SJ, Eikelboom J, Giugliano RP, Morrow DA, ......Granger CB*.
Circulation. 2022; 145(4): 242-255. (IF: 39.922)
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
2022
Chan CH, Hu YF*, Chen PF, Wu IC, Chen SA.
Acta Cardiol. Sin. 2022; 38(2): 124-133. (IF: 1.800)
Exercise Test for Patients with Long QT Syndrome.
2022
Chan CS, Lin FJ, Liu CM, Lin YK, Chen YC, Hsu CC*, Higa S, Chen SA, Chen YJ*.
Exp. Ther. Med. 2022; 24(6):720. (IF: 2.751)
Mirabegron, a beta 3-adrenoreceptor agonist, regulates right and left atrial arrhythmogenesis differently.
2022
Chan YH*, Chao TF, Chen SW, Kao YW, Huang CY, Chu PH*.
Eur. Heart J.-Qual. Care Clin. Outcomes. 2022; qcac040. (IF: 7.064)
Association of acute increases in serum creatinine with subsequent outcomes in patients with type 2 diabetes mellitus treated with sodium-glucose cotransporter 2 inhibitor or dipeptidyl peptidase-4 inhibitor.
2022
Chan YH, Chao TF, Chen SW, Lee HF, Li PR, Chen WM, Yeh YH, Kuo CT, See LC, Lip GYH*.
Cardiovasc. Diabetol. 2022; 21(1):118. (IF: 8.949)
The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors: a nationwide cohort study.
2022
Chang CY, Gau ML, Huang CJ, Cheng HM*.
PLoS One. 2022; 17(1):e0261493. (IF:3.752)
Effects of non-pharmacological coping strategies for reducing labor pain: A systematic review and network meta-analysis.
2022
Chang HC, Huang WM, Yu WC, Cheng HM, Guo CY, Chiang CE, Chen CH, Sung SH.
J. Am. Heart Assoc. 2022; 11(7): e023422. (IF: 6.107)
Prognostic Role of Pulmonary Function in Patients With Heart Failure With Reduced Ejection Fraction.
2022
Chang HC, Kuo TT, Chen YY, Lin YJ, Chang HY, Hung CL*, Chung FP*.
Diabetes Care. 2022; 45(9): E129-E130. (IF: 17.155)
Sodium-Glucose Cotransporter 2 Inhibitors in Cardiovascular and Renal Outcomes in Patients With Diabetes but Without Established Cardiovascular Disease: A Nationwide Population-Based Cohort Study.